SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cells
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Amyloid beta-peptide (Abeta) deposition in cerebral vessels contributes to cerebral amyloid angiopathy (CAA) in Alzheimer's disease (AD). Here, we report that in AD patients and two mouse models of AD, overexpression of serum response factor (SRF) and myocardin (MYOCD) in cerebral vascular smooth muscle cells (VSMCs) generates an Abeta non-clearing VSMC phenotype through transactivation of sterol regulatory element binding protein-2, which downregulates low density lipoprotein receptor-related protein-1, a key Abeta clearance receptor. Hypoxia stimulated SRF/MYOCD expression in human cerebral VSMCs and in animal models of AD. We suggest that SRF and MYOCD function as a transcriptional switch, controlling Abeta cerebrovascular clearance and progression of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the low-density lipoprotein receptor–related protein-1, a critical Aβ brain clearance receptor, is downregulated in cerebral blood vessels of patients with Alzheimer disease, leading to accumulation of amyloid around blood vessels and worsening of vascular dysfunction.129”
From Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2011) · cites this paper as [129]
Experimental — accuracy not yet measuredIn the citing paper
“In particular, suppression of LRP1 in vascular smooth muscle cells due to upregulation of serum response factor and myocardin, is a key factor in the clearance impairment (Bell et al., 2009).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Bell et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · cited 1×
“dtd" [ ]> Dementia in Alzheimer's disease (AD) is associated with neurovascular dysfunctio”
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022066 · Cited by 2,313
Neurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213 · cited 1×
“dtd" [ ]> Dementia in Alzheimer's disease (AD) is associated with neurovascular dysfunctio”
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413 · cited 1×
“The low-density lipoprotein receptor-related protein 1 (LRP) is a major Aβ clearance receptor at the BB”
BackgroundWolozin, B. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1439 · Cited by 1,398 · cited 1×
“Previous studies have shown that people chronically treated with cholesterol-lowering drugs, such as statins, are less prone to develop A”
BackgroundAdult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909
Wang, D.-Z., Chang, P. S., Wang, Z., Sutherland, L., Richardson, J. A., Small, E., Krieg, P. A., & Olson, E. N. (2001) · Cell · doi:10.1016/s0092-8674(01)00404-4 · Cited by 898
LRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ Isoforms
Deane, R., Wu, Z., Sagare, A., Davis, J., Du Yan, S., Hamm, K., Xu, F., Parisi, M., LaRue, B., Hu, H. W., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.017 · Cited by 828
Self-citation
Research works printed but not linked: 1
- Holtzman, D. M. et al. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Ann. Neurol. 47, 739–747 (2000). · doi:10.1002/1531-8249(200006)47:6<739::aid-ana6>3.0.co;2-8
Cited by
Items 201–262 of 262
SRF deletion results in earlier disease onset in a mouse model of amyotrophic lateral sclerosis
Song, J., Dikwella, N., Sinske, D., Roselli, F., & Knöll, B. (2023) · JCI Insight · doi:10.1172/jci.insight.167694 · Cited by 10
“Similarly, in pathology, neuronal activity elicited by traumatic brain injury (36), Alzheimer’s disease (50, 51) and epilepsy (25, 26) are targeting SRF.”
BackgroundHypoxia Marker Carbonic Anhydrase IX Is Present in Abdominal Aortic Aneurysm Tissue and Plasma
Grossmannova, K., Baráthová, M., Belvončíková, P., Lauko, V., Csáderová, L., Tomka, J., Dulka, T., Pastorek, J., & Maďarič, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020879 · Cited by 7
“A link between hypoxia and myocardin was shown in human VSMC where hypoxia increased myocardin at both mRNA and protein levels [36].”
BackgroundThe Blood–Brain Barrier: An Introduction to Its Structure and Function
Mahringer, A., Ott, M., & Fricker, G. (2013) · Topics in medicinal chemistry · doi:10.1007/7355_2013_20 · Cited by 11
Su, Q., Liu, Q., Li, B., Ma, Z., Bai, F., Li, Y., Yu, X., Li, M., Li, J., & Sun, D. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02844-5 · Cited by 6
Cecelja, M., McNally, R., Cleary, J. O., & Chowienczyk, P. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.040013 · Cited by 7
“64 Our findings are consistent with 1 other systematic review that examined the association between structural changes in the brain and PP 65 and found a cross-sectional association between PP and WMH but not longitudinal change in WMH.”
Kim, G. H., Kim, B. R., Yoon, H., & Jeong, J. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-68916-4 · Cited by 6
“This condition leads to brain hypoperfusion, diminished functional hyperemia, and cerebral amyloid angiopathy 25,26 .”
BackgroundHou, H., Habib, A., Zi, D., Tian, K., Tian, J., Giunta, B. N., Sawmiller, D. R., & Tan, J. (2017) · NeuroMolecular Medicine · doi:10.1007/s12017-017-8446-x · Cited by 6
Langlois, B., Martin, J., Schneider, C., Hachet, C., Terryn, C., Rioult, D., Martiny, L., Thérêt, L., Salesse, S., & Dedieu, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.981927 · Cited by 5
Alzheimer’s Disease and Diabetes
Brent, D. A., Gary, L., Aboud, Z., & Gordon, W. (2013) · InTech eBooks · doi:10.5772/54913 · Cited by 8
“In vascular smooth muscle cells (VSMCs), Aβ affects cellular morphological changes [120] and increases expression of transcription factors, serum response factor and myocardin, resulting in decreased Aβ clearance by downregulating LRP expression [12].”
BackgroundInfluentialCharacteristics of the CArG-SRF binding context in mammalian genomes
Wu, W., Shen, X., & Tao, S. (2009) · Mammalian Genome · doi:10.1007/s00335-009-9238-x · Cited by 6
“Moreover, SRF has been linked to an increasing number of diseases, including cancer (Bell et al. 2009; Koegel et al. 2009; Petit et al. 2008; Zhang et al. 2005).”
BackgroundTwo Faces of Evil: Cancer and Neurodegeneration
Curran, T., & Christen, Y. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-16602-0 · Cited by 5
Amyloid Beta–Mediated Neurovascular Toxicity in Alzheimer’s Disease
Banerjee, S., & Banerjee, S. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3662-6_26 · Cited by 6
Identification of a Qualitative Signature for the Diagnosis of Dementia With Lewy Bodies
Zhou, S. W., Meng, Q., Li, L., Hai, L., Wang, Z., Li, Z., & Sun, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.758103 · Cited by 4
“They function as a transcriptional switch in the Aβ cerebrovascular clearance and progression of AD (Bell et al., 2009).”
BackgroundCerebral hypoperfusion exacerbates traumatic brain injury in male but not female mice
Whitehead, B. J., Corbin, D. R., Alexander, M. L., Bumgarner, J. R., Zhang, N., Karelina, K., & Weil, Z. M. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16439 · Cited by 4
A Systematic Analysis of Genomic Changes in Tg2576 Mice
Tan, L., Wang, X., Ni, Z.-F., Zhu, X., Wu, W., Zhu, L., & Liu, D. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8384-4 · Cited by 4
“Consistent with our finding, several previous studies have suggested that serum response factor and myocardin, which are two interacting TF overexpressed in AD, can block Aβ clearance [24].”
Sena, P. P., Friedrich, L., Villarreal, A. E., Fath, F., Sopco, L., Hernández‐Guillamón, M., Pereira, M. L. S., Britton, G. B., Weber, J. J., & Schmidt, T. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1681079 · Cited by 6
Improving mouse models for the study of Alzheimer's disease
Reagan, A. M., Onos, K. D., Heuer, S. E., Sasner, M., & Howell, G. R. (2022) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2021.12.005 · Cited by 5
Mendel, T. A., & Gromadzka, G. (2010) · Neurologia i Neurochirurgia Polska · doi:10.1016/s0028-3843(14)60157-2 · Cited by 3
Nutrient signaling pathways regulate amyloid clearance and synaptic loss in Alzheimer’s diseasePreprint
Mondal, M., Bali, J., Tzioras, M., Paolicelli, R. C., Jawaid, A., Malnar, M., Dominko, K., Udayar, V., Halima, S. B., Vadodaria, K. C., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.13.381186 · Cited by 3
“…provides additional neuronal Aβ clearance through non-cell autonomous mechanisms via microglia (Chung et al., 1999), interstitial fluid to CSF bulk flow, efflux through blood brain barrier (Bell et al., 2009; Shibata et al., 2000) and enzymatic degradation (Iwata et al., 2000; Qiu et al., 1998).”
BackgroundRozeboom, A., Broekaart, D. W. M., Anink, J. J., Boonkamp, L., Idema, S., Teunissen, C. E., Aronica, E., Gorter, J. A., & van Vliet, E. A. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115149 · Cited by 2
Yata, V. K., Das, O. P., Dansana, J., Gadtya, A., Meher, B. R., Bukke, S. P. N., & Kolliputi, N. (2025) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2025.1709505 · Cited by 2
O’Leary, J. C., Koren, J., & Dickey, C. A. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9540-4 · Cited by 2
“Hypoxia has been shown to decrease the ability of VSMC to clear Aβ (Bell et al. 2009).”
BackgroundVascular Dysfunction and Neurodegenerative Disease
Gao, Z., Cilento, E. M., Stewart, T., & Zhang, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-25249-6_1 · Cited by 2
Transcriptional and post-transcriptional responses to amyloid- β in cerebral amyloid angiopathy
Florijn, B. W., Verwey, N. A., van Etten, E. S., de Vries, H. E., & Wermer, M. J. H. (2025) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x251366082 · Cited by 1
“50 Similarly, in cortical and lep-tomeningeal blood vessels from individuals with AD, a decreased VSMC specific expression of neprilysin (a peptidase that participates in A b degradation and clearance) was seen, which coincided with increased A b deposition.”
InfluentialCastellano, J., Aledo, R., Sendra, J., Costales, P., Badimón, L., & Llorente‐Cortés, V. (2012) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2012.01.006 · Cited by 1
Vascular Smooth Muscle Cell Phenotypic Adaptation
Miano, J. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381510-1.00095-8 · Cited by 1
Self-citationMolecular aspects of regeneration and neuroprotection in neurotraumatic diseases
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821711-5.00006-1 · Cited by 1
Effects of Long Term Consumption of High Calorie Diet on Neurological Disorders
Farooqui, A. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-15254-7_9 · Cited by 1
Cerebral hemorrhages in traumatic brain injury
Irimia, A., Rostowsky, K. A., Law, E. M., & Chui, H. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823347-4.00030-0 · Cited by 1
Nguyen, H. D., Jo, W. H., Cha, J. O., Hoang, N. M. H., & Kim, M.-S. (2024) · Toxicological Research · doi:10.1007/s43188-024-00228-1 · Cited by 1
“In a study on patients with AD with cerebral amyloid angiopathy, Srf was found to be overexpressed in human cerebral vascular smooth muscle cells and small cerebral leptomeningeal arteries, which was related to insoluble A β generation [53].”
Uncommon – monogenetic – causes of small-vessel stroke
Jastrzębski, K., Kacperska, M. J., & Figlus, M. (2014) · Aktualności Neurologiczne · doi:10.15557/an.2014.0004 · Cited by 2
Revuelta‐López, E., Castellano, J., de Gonzalo‐Calvo, D., Nasarre, L., Badimón, L., & Llorente‐Cortés, V. (2015) · Conference Papers in Science · doi:10.1155/2015/283909 · Cited by 2
“Indeed, differences in the modulation of SREBPs by hypoxia explain why LRP1 is downregulated in cerebral VSMC [28] but upregulated in coronary VSMC [11].”
BackgroundContribution of Neuroinflammation in the Pathogenesis of Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00006-9 · Cited by 1
What caused this intracerebral hemorrhage?
Radmanesh, F., & Rosand, J. M. (2019) · Wiley eBooks · doi:10.1002/9781118492390.ch8 · Cited by 1
Aguilar-Pineda, J. A., Vera-López, K. J., Shrivastava, P., Nieto-Montesinos, R., Chávez‐Fumagalli, M. Á., Dávila-Del-Carpio, G., Valdez, B. G., Miller, C. L., Malhotra, R. K., Lindsay, M. E., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.13.439741 · Cited by 1
PET and SPECT Studies of Ageing and Cardiovascular Risk Factors for Alzheimer’s Disease
Busatto, G. F., Tamashiro-Duran, J. H., de Toledo, T. C., Ferreira, L. K., Duran, F., & Buchpiguel, C. A. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_21
Flavonoids as regulators of amyloid precursor protein processing
Cox, C. J. (2014) · The University of Bath Online Publications Store (The University of Bath)
Actin-SRF Signaling in the Developing and Mature Murine Brain
Nordheim, A., & Knöll, B. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-16602-0_3
Merlin, J. L. P. (2013) · Journal of the Chosun Natural Science · doi:10.13160/ricns.2013.6.3.125
“Binding of Aβ to LRP1 initiates Aâ clearance from brain to blood via transcytosis across the BBB([18,28]).”
BackgroundInfluentialNew Molecule Found to Cross the Blood-Brain Barrier
Valeo, T. (2009) · Neurology Today · doi:10.1097/01.nt.0000367466.11687.41
PREDICCIÓN IN SILICO DE LA INTERACCIÓN ENTRE LA PRAVASTATINA Y LA MIOCARDINA
Maria, O. O. L., Esteban, G. Z. D., Marcela, P. G. L., Lucia, V. D., Janneth, G. S., & Barreto, G. E. (2012) · Primer Congreso Virtual de Ciencias Morfológicas
Stroke, Cognitive Function, and Alzheimer’s Disease
Jackman, K. A., Cumming, T. B., & Miller, A. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802851-3.00011-5 · Cited by 1
Pericytes of the Central Nervous System
Krueger, M. W., & Bechmann, I. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199794591.003.0009
Microglia and Complement in Alzheimer's Disease with Cerebral Amyloid Angiopathy
Zabel, M. K. (2013) · The Scholars Repository - LLU (Loma Linda University)
The Search for Biomarkers in Alzheimer's Disease
Meiliana, A., & Wijaya, A. (2010) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v2i1.107 · Cited by 3
NRP1 regulation of endothelial cell signalling
Λαμπροπούλου, Α. (2017) · UCL Discovery (University College London)
Microfabrication Approaches for Understanding the Role of Vascular Mechanics in Progressive Diseases
Hald, E. S. (2016) · University of Minnesota Digital Conservancy (University of Minnesota)
The role of NPxY domains in LRP1 receptor maturation and function
Pflanzner, T. (2011) · Gutenberg Open Science · doi:10.25358/openscience-3281
The Clinical Research Progress in Vascular Cognitive Impairment
方, 咏. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.142421
Wang, Y., Liu, H., Ni, Z., Liu, Y., Deng, X., Huang, Y.-Q., Li, S., Tie, J.-J., Wu, F., Zhu, C.-L., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-5607179/v1
Research Progress on Pericytes in Central Nervous System Diseases
潘, 浩. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1541306
Wang, S., Luo, G., Zhao, Q., Zhang, S., Li, Z., Lu, J., Wang, F., Sun, D., & Xu, H. M. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251378973
Li, C., Zhang, X., Xia, J., Liu, S., Du, Y., Li, S., Zhang, S., Zhang, Y., Ji, F., Jiao, J., et al. (2025) · Advanced Science · doi:10.1002/advs.202515584
Girolamo, F., de Trizio, I., Errede, M., Longo, G., d’Amati, A., & Virgintino, D. (2021) · Figshare · doi:10.6084/m9.figshare.14431841
Additional file 2 of Identification of key lipid metabolism-related genes in Alzheimer’s disease
Zeng, Y., Cao, S., Li, N., Tang, J., & Lin, G. (2024) · Figshare · doi:10.6084/m9.figshare.26618926
Additional file 1 of Identification of key lipid metabolism-related genes in Alzheimer’s disease
Zeng, Y., Cao, S., Li, N., Tang, J., & Lin, G. (2024) · Figshare · doi:10.6084/m9.figshare.26618923
Robert, J., Button, E. B., Martin, E. M., McAlary, L., Gidden, Z., Gilmour, M., Boyce, G. K., Caffrey, T. M., Agbay, A. M., Clark, A., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12033156
Chung, T. D., Liang, L. R., Wang, L., Kim, E. G., Gupta, S., Pandey, I., & Searson, P. C. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-026-00773-x
Guo, Z., He, X., Ge, Y., Zhao, B. D., Huang, L.-Y., Chen, S., Fu, Y., Gao, P., Sheng, Z.-H., Huang, Y., et al. (2026) · European Journal of Neurology · doi:10.1111/ene.70558
“Hypoxia also stimulates the up-regulation of myocardin and serum response factor in brain vascular smooth muscle cells, contributing to reduced cerebral blood flow and impaired amyloid clearance [51–53].”
Vascular cognitive impairment and dementia: current understanding and future directions
Garg, S., & McCullough, L. D. (2026) · npj Dementia · doi:10.1038/s44400-026-00135-2
Progression of White Matter Hyperintensities in older adults: A systematic review and meta-analysis
Liu, J., & Raz, N. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103393
Metadata
- Authors
- Bell, R. D., Deane, R., Chow, N., Long, X., Sagare, A., Singh, I., Streb, J. W., Guo, H., Rubio, A., Van Nostrand, W., Miano, J. M., & Zlokovic, B. V.
- Affiliations
- University of Rochester Medicine (US)
- Venue
- Nature Cell Biology
- Published
- 2008-12-21
- Volume
- 11
- Issue
- 2
- Pages
- 143-153
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC2654279
- OpenAlex
- W2094117787
- Cited by
- 261
- References
- 52
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 10 · 2023: 9 · 2022: 12 · 2021: 10 · 2020: 9 · 2019: 12 · 2018: 6 · 2017: 19 · 2016: 12 · 2015: 19 · 2014: 20 · 2013: 17 · 2012: 29
- FWCI
- 14.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Chinese Academy of Agricultural Sciences
- National Institutes of Health
- National Institute on Aging (R37AG023084, R42AG026950, 1R43 AG02400)
- National Heart, Lung, and Blood Institute (R01HL132574, HL 62572, R01HL062572, R01HL091168)
- National Institute of Neurological Disorders and Stroke (R37NS034467, R01NS034467, R37NS34467)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- serum response factor, myocardin, LRP1, amyloid-beta clearance, cerebral amyloid angiopathy, Alzheimer's disease, SREBP2, cerebral hypoxia, transcriptional regulation
- MeSH terms
- Myocardin, Aged, Aged, 80 and over, Alzheimer Disease, Animals, Blood-Brain Barrier, Cells, Cultured, Cerebral Arteries, Disease Models, Animal, Female, Humans, Male, Mice, Transgenic, Muscle, Smooth, Vascular, Nuclear Proteins, Transcriptional Activation, Trans-Activators, Down-Regulation, Amyloid beta-Peptides, Serum Response Factor, Low Density Lipoprotein Receptor-Related Protein-1, Mice, Sterol Regulatory Element Binding Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.